Cargando…
Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (NCBP2) in colon adenocarcinoma
BACKGROUND: Colon adenocarcinoma (COAD) is an incurable malignancy and the third most common tumor worldwide. Advances in biomarkers screening have greatly contributed to explore the new diagnostic and prognostic biomarkers for the early detection and prognostic of COAD. However, the heterogeneity-s...
Autores principales: | Bu, He, Cao, Ting, Li, Xuesong, Guo, Yuekun, Guo, Jiajia, Wang, Yuxin, Sun, Yunlong, Wang, Donghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459195/ https://www.ncbi.nlm.nih.gov/pubmed/36092349 http://dx.doi.org/10.21037/jgo-22-665 |
Ejemplares similares
-
mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3
por: Gebhardt, Anna, et al.
Publicado: (2015) -
Exploring metabolic biomarkers and regulation pathways of acute pancreatitis using ultra-performance liquid chromatography combined with a mass spectrometry-based metabolomics strategy
por: Guo, Jiajia, et al.
Publicado: (2019) -
NCBP1 promotes the development of lung adenocarcinoma through up‐regulation of CUL4B
por: Zhang, Huijun, et al.
Publicado: (2019) -
NCBP3 positively impacts mRNA biogenesis
por: Dou, Yuhui, et al.
Publicado: (2020) -
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
por: Arora, Rahul, et al.
Publicado: (2023)